Company profile: Clinvest Research
1.1 - Company Overview
Company description
- Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
Products and services
- Diabetes & Weight Loss Studies: Condition-targeted studies that research diabetes and weight management, focusing on new treatments and health strategies for better health outcomes
- Vaccine Studies: Pharmaceutical-partnered research that studies vaccines to understand their role in preventing diseases like flu, RSV, and COVID, conducted with pharmaceutical companies
- Clinical Trials: Multi-condition clinical programs conducting trials for migraine, arthritis, diabetes, and vaccines, delivering access to new treatments before they are widely available
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clinvest Research
Denison Pharmaceuticals
HQ: United States
Website
- Description: Provider of turn-key formulation, manufacturing, packaging, and testing solutions for branded OTC, Rx, and cosmetic markets. Services include technical operations from concept to commercialization; commercial manufacturing in nine compounding suites up to 2,000 gallons; packaging on 16 high-speed lines for liquids, tubes, jars, and aerosols; cGMP analytical, microbiological, and stability labs; validation and USP Monograph testing; and formulation and reverse-engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Denison Pharmaceuticals company profile →
Ethos Health Communications
HQ: United States
Website
- Description: Provider of medical and marketing communications services, offering medical affairs to analyze complex data and landscapes; KOL data solutions to identify, map, and track thought leader influence; training, learning and development across the product life cycle; pharma marketing for commercialization, launch planning, and multichannel execution; digital opinion leader mapping in healthcare; and scientific communications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethos Health Communications company profile →
BioClin Labs
HQ: Ireland
Website
- Description: Provider of internationally recognised expert analytical services and rapid reporting of data to support drug development and product release, leveraging breadth of scientific experience and knowledge across a wide range of techniques to develop optimal methods that run efficiently and meet regulatory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioClin Labs company profile →
Cody Labs
HQ: United States
Website
- Description: Provider of active pharmaceutical ingredients (APIs) and finished dosage forms of pain relief medication, as well as CodyLabs – Cinema Browser, a web browser for movie enthusiasts with integration to streaming services, support for various video formats, automatic subtitle synchronization, and picture-in-picture mode.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cody Labs company profile →
Abveris
HQ: United States
Website
- Description: Provider of antibody discovery solutions for reagent and therapeutic applications, offering DiversimAb hyperimmune mouse technology for diverse monoclonal antibodies; Beacon single B-cell screening; hybridoma discovery (production, purification, sequencing, recombinant production); antigen production and design; anti-idiotype antibody discovery; and fully human antibodies via humanized mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abveris company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clinvest Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clinvest Research
2.2 - Growth funds investing in similar companies to Clinvest Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clinvest Research
4.2 - Public trading comparable groups for Clinvest Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →